Brief: Kiniksa Pharmaceuticals Reports Q4 And Full-Year 2022 Financial Results

Kiniksa Pharmaceuticals International

28/02/2023 14:01

Feb 28 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS REPORTS FOURTH QUARTER AND
FULL-YEAR
2022 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION
    * KINIKSA PHARMACEUTICALS LTD: EXPECTS ARCALYST NET PRODUCT
REVENUE FOR FULL-YEAR 2023 OF BETWEEN $190 MILLION AND $205
MILLION
    * KINIKSA PHARMACEUTICALS LTD - EXPECTS THAT ITS CASH AND
CASH
EQUIVALENTS WILL FUND ITS CURRENT OPERATING PLAN INTO AT LEAST
2025

Source text for Eikon:  ID:nGNX1DPbnb 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))